Marshall, Gerstein & Borun LLP
日本 中国
  • About
  • Professionals
  • Practices & Industries
  • Client Successes
  • Diversity
  • Careers
  • Resources
    • Firm News
    • Events
    • Insights
    • PTABWatch Blog
  • Contact
  • Professionals
  • Practices & Industries
  • Client Successes
  • About
    • About Our Firm
    • Awards & Rankings
    • Pro Bono
    • Diversity and Inclusion
      • Dedicated Action
      • Community Outreach
      • Awards & Rankings
    • Firm History
  • Careers
    • Careers at Marshall Gerstein
    • On-Campus Recruiting
  • News & Resources
    • Firm News
    • Events
    • Insights
    • PTABWatch Blog
  • 中国 (CN)
  • 日本 (JP)
Insights

“Sequenom Patent Invalidation May Have Ramifications for NIPT Field, Entire MDx Industry” (featured quotes)

June 16, 2015
GenomeWeb
Share This Page

Partner David A. Gass was quoted in GenomeWeb's article “Sequenom Patent Invalidation May Have Ramifications for NIPT Field, Entire MDx Industry” on June 16, 2015.

Associated People

David A. Gass

David A. Gass

Associated Practices

  • Patent Prosecution

Associated Industries

  • Biotechnology & Life Sciences
  • Pharmaceutical
  • Subscribe
  • Disclaimer
  • Cookie Policy
  • Privacy Statement
  • Attorney Advertising
  • Credits
© 2021 Marshall, Gerstein & Borun LLP, All Rights Reserved.
Marshall, Gerstein & Borun LLP, 233 South Wacker Drive, 6300 Willis Tower, Chicago, IL 60606-6357 t. 312.474.6300
Marshall, Gerstein & Borun LLP
Email Disclaimer

Please note that email communications sent through this website do not create an attorney-client relationship between you and our firm, and will not prevent us from representing another person or company involved in the same matter that is the subject of your message. Unless you are already a client of Marshall, Gerstein & Borun LLP, do not send any information that you consider privileged or confidential. Click “Accept” below to confirm that you have read and understand this message.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.